miR-222 induces Adriamycin resistance in breast cancer through PTEN/Akt/p27kip1 pathway.
about
Naturally existing isoforms of miR-222 have distinct functions.Elevated levels of serum MiR-152 and miR-24 in uterine sarcoma: potential for inducing autophagy via SIRT1 and deacetylated LC3.MiR-221/222 promote chemoresistance to cisplatin in ovarian cancer cells by targeting PTEN/PI3K/AKT signaling pathway.miR-222 promotes invasion and migration of ovarian carcinoma by targeting PTEN.The Network of Non-coding RNAs in Cancer Drug Resistance
P2860
miR-222 induces Adriamycin resistance in breast cancer through PTEN/Akt/p27kip1 pathway.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
miR-222 induces Adriamycin resistance in breast cancer through PTEN/Akt/p27kip1 pathway.
@en
type
label
miR-222 induces Adriamycin resistance in breast cancer through PTEN/Akt/p27kip1 pathway.
@en
prefLabel
miR-222 induces Adriamycin resistance in breast cancer through PTEN/Akt/p27kip1 pathway.
@en
P2093
P2860
P1433
P1476
miR-222 induces Adriamycin resistance in breast cancer through PTEN/Akt/p27kip1 pathway.
@en
P2093
Dan-Dan Wang
Hong-Yu Shen
Jian-Hua Zhao
Jin-Hai Tang
Long-Ji Luo
Shan-Liang Zhong
Su-Jin Yang
Xiao-Hui Zhang
P2860
P2888
P304
15315-15324
P356
10.1007/S13277-016-5341-2
P577
2016-10-04T00:00:00Z
P6179
1003802078